26th week of 2018 patent applcation highlights part 7 |
Patent application number | Title | Published |
20180177719 | PHARMACEUTICAL COMPOSITIONS | 2018-06-28 |
20180177720 | Chewable Composition and Delivery Pouch | 2018-06-28 |
20180177721 | Manufacture of Pharmaceutical Compositions | 2018-06-28 |
20180177722 | Coenzyme Q10 Aerosol | 2018-06-28 |
20180177723 | COMPOSITION AND METHOD OF PRODUCING NANOFORMULATION OF WATER INSOLUBLE BIOACTIVES IN AQUEOUS BASE | 2018-06-28 |
20180177724 | SITE-TARGETED NANO-LIPOSOMAL NITROGLYCERIN THERAPEUTICS | 2018-06-28 |
20180177725 | CELL MEMBRANE-FORMED NANOSCALE VESICLES AND METHODS OF USING THEREOF | 2018-06-28 |
20180177726 | USE OF LIPOSOMES IN A CARRIER COMPRISING A CONTINUOUS HYDROPHOBIC PHASE AS A VEHICLE FOR CANCER TREATMENT | 2018-06-28 |
20180177727 | USE OF EXOSOMES FOR THE TREATMENT OF DISEASE | 2018-06-28 |
20180177728 | NANOPARTICLES | 2018-06-28 |
20180177729 | G PROTEIN-COUPLED RECEPTORS INCORPORATED INTO REHYDRATED POLYMER VESICLES RETAIN FUNCTIONALITY | 2018-06-28 |
20180177730 | MICROSPHERES CONTAINING ANTHELMINTIC MACROCYCLIC LACTONES | 2018-06-28 |
20180177731 | Composite Preparation of Mosapride and Rabeprazole | 2018-06-28 |
20180177732 | OXIDATION-STABILIZED TAMPER-RESISTANT DOSAGE FORM | 2018-06-28 |
20180177733 | RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION | 2018-06-28 |
20180177734 | PHARMACEUTICAL FORMULATIONS COMPRISING TENOFOVIR AND EMTRICITABINE | 2018-06-28 |
20180177735 | Stable Pharmaceutical Composition Of Phytonadione And A Novel Process For Preparation Thereof | 2018-06-28 |
20180177736 | Cell Lines and Their Use in Encapsulated Cell Biodelivery | 2018-06-28 |
20180177737 | INSTRUMENT FOR SKIN TREATMENT | 2018-06-28 |
20180177738 | STABILIZED POLYMERIC NANOCAPSULES, DISPERSIONS COMPRISING THE NANOCAPSULES, AND METHODS FOR THE TREATMENT OF BACTERIAL BIOFILMS | 2018-06-28 |
20180177739 | DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF | 2018-06-28 |
20180177740 | NON-NATURAL FIBER OR FILAMENT WITH HERBAL RESIDUE AND METHOD OF MAKING THE SAME | 2018-06-28 |
20180177741 | Thin Film With Non-Self-Aggregating Uniform Heterogeneity And Drug Delivery Systems Made Therefrom | 2018-06-28 |
20180177742 | NON-AQUEOUS PATCH COMPRISING LIDOCAINE | 2018-06-28 |
20180177743 | METHOD OF TREATING PAIN USING RACEMIC MIXTURE OF S-KETAMINE AND R-KETAMINE | 2018-06-28 |
20180177744 | METHOD OF TREATING PAIN AND DEPRESSION USING A HYBRID MIXTURE OF S-KETAMINE AND R-KETAMINE | 2018-06-28 |
20180177745 | Application Of R-ketamine And Salt Thereof As Pharmaceuticals | 2018-06-28 |
20180177746 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT | 2018-06-28 |
20180177747 | Paediatric Compositions For Treating Multiple Sclerosis | 2018-06-28 |
20180177748 | COMBINATION MEDICATION FOR NEURO-DEGENERATIVE DISEASES | 2018-06-28 |
20180177749 | USE OF CYP EXPRESSION TO DIRECT THERAPEUTIC INTERVENTION IN CANCER | 2018-06-28 |
20180177750 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ENHANCER OF ZESTE HOMOLOG 2 POLYPEPTIDE | 2018-06-28 |
20180177751 | VALPROIC ACID FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION | 2018-06-28 |
20180177752 | PHARMACEUTICAL SUSPENSIONS CONTAINING DRUG PARTICLES, DEVICES FOR THEIR ADMINISTRATION, AND METHODS OF THEIR USE | 2018-06-28 |
20180177753 | GLYCERYL 3-HYDROXYBUTYRATES FOR MIGRAINE SYMPTOM MANAGEMENT | 2018-06-28 |
20180177754 | COMPOSITIONS FOR USE IN TREATING PULMONARY ARTERIAL HYPERTENSION | 2018-06-28 |
20180177755 | METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs | 2018-06-28 |
20180177756 | A 19-144, A2-73 AND CERTAIN ANTICHOLINESTERASE INHIBITOR COMPOSITIONS AND METHOD FOR ANTI-SEIZURE THERAPY | 2018-06-28 |
20180177757 | ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS | 2018-06-28 |
20180177758 | COMPOUNDS FOR TREATMENT OF ANGIOGENESIS-MEDIATED DISEASES | 2018-06-28 |
20180177759 | COMBINATION OF AN ANTIANDROGEN WITH A VITAMIN K ANTAGONIST OR WITH A GAMMA-GLUTAMYL CARBOXYLASE INHIBITOR FOR THE THERAPY OF ANDROGEN RECEPTOR POSITIVE CANCER | 2018-06-28 |
20180177760 | COMPOSITIONS COMPRISING BIOREVERSIBLE DERIVATIVES OF HYDROXY N-SUBSTITUTED-2-AMINOTETRALINS, AND RELATED DOSAGE FORMS | 2018-06-28 |
20180177761 | AMINO COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | 2018-06-28 |
20180177762 | ANTI-DANDRUFF COMPOSITIONS COMPRISING A SPIROFURANONE LACTAM TETRAMIC ACID DERIVATIVE | 2018-06-28 |
20180177763 | SMALL MOLECULES THAT MIMIC OR ANTAGONIZE ACTIONS OF GRANULOCYTE COLONY-STIMULATING-FACTOR (G-CSF) | 2018-06-28 |
20180177764 | TREATMENT OF CARDIAC DISORDERS BY BLOCKING SK4 POTASSIUM CHANNEL | 2018-06-28 |
20180177765 | Compositions and Methods employing Wolbachia FtsZ as a target for Albendazole sulfone | 2018-06-28 |
20180177766 | THERAPEUTIC AGENT FOR NEUROTROPHIC KERATOPATHY | 2018-06-28 |
20180177767 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | 2018-06-28 |
20180177768 | METHODS AND COMPOSITIONS TO TREAT CANCER | 2018-06-28 |
20180177769 | 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase | 2018-06-28 |
20180177770 | METHODS OF TREATING EPITHELIOID CELL TUMORS | 2018-06-28 |
20180177771 | BIOMARKERS FOR NANOPARTICLE COMPOSITIONS | 2018-06-28 |
20180177772 | METHODS OF TREATING GLIOBLASTOMA MULTIFORME USING IBUDILAST | 2018-06-28 |
20180177773 | USE OF ANTI-CONNEXIN AGENTS FOR ENHANCING THE THERAPEUTIC EFFECT OF ACETYLCHOLINESTERASE INHIBITORS | 2018-06-28 |
20180177774 | TOPICAL RETINOID COMPOSITIONS | 2018-06-28 |
20180177775 | COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES | 2018-06-28 |
20180177776 | COMPOSITIONS FOR THE TREATMENT OF CANCER AND USES THEREOF | 2018-06-28 |
20180177778 | Methods for Treating HCV | 2018-06-28 |
20180177779 | Methods for Treating HCV | 2018-06-28 |
20180177780 | PYRIDAZINONE COMPOUNDS AND THEIR USE AS DAAO INHIBITORS | 2018-06-28 |
20180177781 | NOVEL CRYSTALLINE FORMS | 2018-06-28 |
20180177782 | NOVEL USES | 2018-06-28 |
20180177783 | COMBINATION THERAPY USING BELINOSTAT AND PRALATREXATE TO TREAT LYMPHOMA | 2018-06-28 |
20180177784 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 2018-06-28 |
20180177785 | Method of Making Sustained Release Microparticles | 2018-06-28 |
20180177786 | MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER | 2018-06-28 |
20180177787 | 3-(3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINE AND THERAPEUTIC USES THEREOF | 2018-06-28 |
20180177788 | THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE | 2018-06-28 |
20180177789 | COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS | 2018-06-28 |
20180177790 | COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS | 2018-06-28 |
20180177791 | COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS | 2018-06-28 |
20180177792 | COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH RTK MUTANT CELLS | 2018-06-28 |
20180177793 | CYCLIC AMINES | 2018-06-28 |
20180177794 | METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT | 2018-06-28 |
20180177795 | ISOQUINOLIDINOBENZODIAZEPINE (IQB)-1(CHLOROMETHYL)-2,3-DIHYDRO-1H-BENZO[E]INDOLE (CBI) DIMERS | 2018-06-28 |
20180177796 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ANESTHESIOLOGICAL APPLICATIONS | 2018-06-28 |
20180177797 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ANESTHESIOLOGICAL APPLICATIONS | 2018-06-28 |
20180177798 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | 2018-06-28 |
20180177799 | Compositions and Methods for Muscle Regeneration Using Prostaglandin E2 | 2018-06-28 |
20180177800 | COMPOSITION FOR PERCUTANEOUS ABSORPTION | 2018-06-28 |
20180177801 | Application of Antidepressant Compound in Preparation of Antidepressant Drugs and Antidepressant Health-Care Foods | 2018-06-28 |
20180177802 | JOINT APPLICATION OF STATIN AND ADRENOCORTICAL HORMONE FOR TREATING CHRONIC SUBDURAL HEMATOMA | 2018-06-28 |
20180177803 | TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS | 2018-06-28 |
20180177804 | Scalable Vitamin Composition Unit Dosage for the Treatment of Fat-Soluble Vitamin Deficiences | 2018-06-28 |
20180177805 | Intravitreal Lysine Acetylsalicylate As Treatment For Diabetic Retinopathy | 2018-06-28 |
20180177806 | DOSAGE FORM COMPRISING AN ACTIVE INGREDIENT AND A PLURALITY OF SOLID POROUS MICROCARRIERS | 2018-06-28 |
20180177807 | Surfactant Lipids, Compositions Thereof, and Uses Thereof | 2018-06-28 |
20180177808 | METHOD FOR TREATING CANCER USING CHEMOKINE ANTAGONISTS | 2018-06-28 |
20180177809 | COMPOSITION COMPRISING HMSs/HMOs AND USE THEREOF | 2018-06-28 |
20180177810 | MULTIFUNCTIONAL MICELLAR NANOPARTICLE-BASED DRUG AND TARGETING AGENT SYSTEM | 2018-06-28 |
20180177811 | GLUCORAPHNIN FOR USE IN THE TREATMENT AND/OR PREVENTION OF DIABETES MELLITUS | 2018-06-28 |
20180177812 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS | 2018-06-28 |
20180177813 | TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN | 2018-06-28 |
20180177814 | EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY | 2018-06-28 |
20180177815 | MIRNAS AS NOVEL THERAPEUTIC ADJUVANTS AND BIOMARKERS FOR THE PROGNOSIS AND TREATMENT OF DRUG RESISTANT BREAST CANCERS | 2018-06-28 |
20180177816 | THERAPEUTIC AGENT ASSOCIATED WITH SUPPRESSION OF PROLIFERATION AND METASTASIS OF TUMOR, WHICH COMPRISES EXOSOMES RELEASED FROM CYTOTOXIC T CELLS AND TARGETS CANCER STROMAL/MESENCHYMAL CELLS | 2018-06-28 |
20180177817 | COMPOSITION & METHODS OF SCREENING | 2018-06-28 |
20180177818 | HEMOSTATIC COMPOSITION COMPRISING AN ANION EXCHANGER AND A CALCIUM SALT | 2018-06-28 |
20180177819 | METHOD FOR PREPARING AN INJECTABLE CROSS-LINKED HYDROGEL, HYDROGEL OBTAINED; AND USE OF THE OBTAINED HYDROGEL | 2018-06-28 |